In hepatocellular carcinoma, SMARCA4 activates a series of downstream cascades by directly binding to the Sall4 promoter and enhancing Sall4 transcription, ultimately resulting in enhancing the stemness potency of cancer cells [122]. This evidence concerns the gene SALL4 and hepatocellular carcinoma.